黄芪分子生药学研究进展  

Advances in Molecular Pharmacognosy of Astragalus Membranaceus

作　　者：杨少鹏 马江红 Yang Shaopeng;Ma Jianghong(Dingxi People's Hospital,Dingxi 743000,China;Dingxi Drug Inspection and Testing Center,Dingxi 743000,China)

机构地区：[1]定西市人民医院,甘肃定西743000 [2]定西市药品检验检测中心,甘肃定西743000

出　　处：《亚太传统医药》2024年第8期244-251,共8页Asia-Pacific Traditional Medicine

摘　　要：黄芪是常用临床补气要药,备受关注,通过查阅大量相关文献,综述黄芪的遗传多样性、有效成分的生物合成、种质资源真伪鉴别等分子生药学研究进展,旨在为黄芪资源保护及其进一步开发利用提供参考。Astragalus membranaceus has attracted much attention as a commonly used clinical medicine for tonifying Qi.Through consulting a large number of relevant literatures,to review the research progress of molecular Pharmacognosy of Astragalus membranaceus,such as genetic diversity,biosynthesis of active ingredients,and identification of germplasm resources,to provide references for resource protection,further development and utilization of Astragalus membranaceus.

关 键 词：黄芪 分子生药学 分子标记 生物合成 有效成分 

分 类 号：R282.6[医药卫生—中药学]